Skip to main content

Table 1 Data sharing statements

From: The efficacy and safety of herbal medicine BHH10 in postmenopausal women with osteoporosis: study protocol for a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial

ICMJE requirements

Answer

Will individual participant data be available (including data dictionaries)?

Yes

What data in particular will be shared?

Individual participant data behind the results reported in this article, after deidentification (text, tables, figures, and appendices)

What other documents will be available?

Study protocol

When will data be available (start and end dates)?

Beginning 3 months and ending 5 years following publication of the research

With whom?

Investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose

For what types of analyses?

To achieve the aims in the approved proposal.

By what mechanism will data be made available?

Proposals should be directed to kmdyeeun@gmail.com; to be given access, data requestors must sign a data access agreement